Treatment Management and Factors Affecting Mortality in Retroperitoneal Hemorrhage Due to Cardiac Catheterization; Single Center Experience

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03006120

Enrollment

Registered

2016-12-30

Start date

2010-01-31

Completion date

2016-12-31

Last updated

2017-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mortality, Treatment Procedure

Brief summary

Bleeding complications after cardiac catheterization have been reviewed previously, but there are very few studies on retroperitoneal hematoma and appropriate treatment of patients is not well defined. For this reason, the investigators aimed to analyze the clinical manifestations of retroperitoneal hematomas in a single center using a case-control study design, to analyze the treatment procedure determinants and consequently to provide an updated and usable treatment algorithm.

Interventions

PROCEDURERetroperitoneal hematoma due to cardiac catheterization

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Retroperitoneal hematoma following cardiac catheterization

Exclusion criteria

* Patients with retroperitoneal hematomas other than cardiac catheterization and patients with missing file records.

Design outcomes

Primary

Measure	Time frame
Mortality	01/01/2010- 31/10/2016

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026